Home         Forums  

Go Back   Marrowforums > Treatments > Transplants
Register FAQ Search Today's Posts Mark Forums Read

Transplants Bone marrow and stem cell transplantation

Reply
 
Thread Tools Search this Thread
  #1  
Old Wed Oct 8, 2014, 03:46 PM
Marlene Marlene is offline
Member
 
Join Date: Oct 2006
Location: Springfield, VA
Posts: 1,406
Article: results of Hopkins study

Here's an article with the results of the study on using post BMT chemo to reduce/prevent chronic GVHD. This is the protocol being used in half-match transplants.


http://www.sciencedaily.com/releases...1008122106.htm
__________________
Marlene, wife to John DX w/SAA April 2002, Stable partial remission; Treated with High Dose Cytoxan, Johns Hopkins, June 2002. Final phlebotomy 11/2016. As of July 2021 HGB 12.0, WBC 4.70/ANC 3.85, Plts 110K.
Reply With Quote
  #2  
Old Wed Oct 8, 2014, 04:29 PM
Neil Cuadra Neil Cuadra is offline
Owner
 
Join Date: Jul 2006
Location: Los Angeles, California
Posts: 2,553
It's great news for full-match bone marrow transplant patients. It shows again that they can replace 6 months of immunosuppression with 2 days of cyclophosphamide to help prevent GVHD.

Post-transplant cyclophosphamide also apparently helps with the success of the transplant itself, reducing rejection rates. Cyclophosphamide is used to attack the old (damaged) immune system before the transplant, so it must somehow suppress a response from the old immune system without interfering with the new immune system.
Reply With Quote
  #3  
Old Wed Oct 8, 2014, 05:06 PM
Marlene Marlene is offline
Member
 
Join Date: Oct 2006
Location: Springfield, VA
Posts: 1,406
Amazing to see how much success is coming from a very old drug.
__________________
Marlene, wife to John DX w/SAA April 2002, Stable partial remission; Treated with High Dose Cytoxan, Johns Hopkins, June 2002. Final phlebotomy 11/2016. As of July 2021 HGB 12.0, WBC 4.70/ANC 3.85, Plts 110K.
Reply With Quote
  #4  
Old Thu Oct 9, 2014, 11:47 AM
KMac KMac is offline
Member
 
Join Date: Oct 2012
Location: Golden, Colorado
Posts: 103
I agree Marlene, it makes one wonder what other drugs already exist which could help save lives and restore health for all sorts of illnesses in as-of-yet undiscovered treatment modes.

NIH's discovery that Eltrombopag can treat refractory SAA comes to mind. I wonder without NIH, if the manufacturer or anyone else would have ever discovered this.

At my treatment center (CBCI), they have been using post-BMT chemo treatment for the past couple of years (or longer?), and it seems the statistics have been very good with it for them.
__________________
Kevin, male age 45; dx SAA 02/2012 - Hgb 5.8, platelets 14, ANC 200, 1% cellularity. Received ATG 03/2012. As of 03/2015, significant improvement - Hgb 15, platelets 158, ANC fluctuates around 1000, Lymphocytes 620. Tapering cyclosporine. BMB 20-30% cellularity.
Reply With Quote
Reply


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Research Study Seeking Vietnam War-Era Veterans with MDS Marrowforums MDS 5 Mon Mar 27, 2017 03:27 PM
Article on Italian GVHD study..... Marlene Transplants 0 Thu Feb 3, 2011 04:40 PM
Study Discounts Age Limit on Stem Cell Transplants Marrowforums News and Events 0 Fri Dec 12, 2008 12:10 PM
Romiplostim Study Results Announced Wendy Beltrami Drugs and Drug Treatments 3 Sun Dec 16, 2007 06:53 AM


All times are GMT -4. The time now is 09:38 PM.


Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org